APA

Carlo M. I., Manley B., Patil S., Woo K. M., Coskey D. T., Redzematovic A., Arcila M., Ladanyi M., Lee W., Chen Y. B., Lee C. H., Feldman D. R., Hakimi A. A., Motzer R. J., Hsieh J. J. & Voss M. H. (2017). Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma. : Kidney cancer (Clifton, Va.).

Chicago

Carlo M I, Manley B, Patil S, Woo K M, Coskey D T, Redzematovic A, Arcila M, Ladanyi M, Lee W, Chen Y B, Lee C H, Feldman D R, Hakimi A A, Motzer R J, Hsieh J J and Voss M H. 2017. Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma. : Kidney cancer (Clifton, Va.).

Harvard

Carlo M. I., Manley B., Patil S., Woo K. M., Coskey D. T., Redzematovic A., Arcila M., Ladanyi M., Lee W., Chen Y. B., Lee C. H., Feldman D. R., Hakimi A. A., Motzer R. J., Hsieh J. J. and Voss M. H. (2017). Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma. : Kidney cancer (Clifton, Va.).

MLA

Carlo M I, Manley B, Patil S, Woo K M, Coskey D T, Redzematovic A, Arcila M, Ladanyi M, Lee W, Chen Y B, Lee C H, Feldman D R, Hakimi A A, Motzer R J, Hsieh J J and Voss M H. Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma. : Kidney cancer (Clifton, Va.). 2017.